Product Information

DOXYCYCLINE MONO 100 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2225 per EA under NDC 62332025050. Its NADAC has been published 464 times since Jan 3, 2018.

FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXYCYCLINE MONO 100 MG CAP

Doxycycline
$0.2225per EA

Strength

100 mg/1

NDC

62332025050

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXYCYCLINE

Approval Type

Generic (ANDA)

FDA Application

ANDA209165

FDA Approved

7/28/2017

TE Code

AB

On Market Since

7/31/2017

Pharmacological Classes

Price Statistics

The NADAC for DOXYCYCLINE MONO 100 MG CAP has been published 464 times since Jan 3, 2018, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2225 per EA
All-time high$0.3479 (Oct 10, 2018)
All-time low$0.1624 (Nov 20, 2024)
52-week high$0.2397
52-week low$0.2225
Median price$0.2550
Average price$0.2573
Largest weekly change-35.2% (Nov 20, 2024)
Weeks tracked464
Tracking sinceJan 3, 2018

Price History

1W

-0.9%

1M

-0.9%

3M

-4.2%

6M

-5.2%

1Y

-5.7%

3Y

-7.5%

5Y

-14.8%

All

-35.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXYCYCLINE MONO 100 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 100 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.2225 per EA (NDC 62332025050), effective Nov 18, 2026.

How has the price of DOXYCYCLINE MONO 100 MG CAP changed over time?

Over the history we have for it, the NADAC for DOXYCYCLINE MONO 100 MG CAP has declined 35.2%. It has been tracked across 464 weekly CMS publications since Jan 3, 2018.

What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 100 MG CAP?

Since Jan 3, 2018, the NADAC for DOXYCYCLINE MONO 100 MG CAP has ranged from a low of $0.1624 (Nov 20, 2024) to a high of $0.3479 (Oct 10, 2018), with a median of $0.2550 per EA.

Are there cheaper alternatives to DOXYCYCLINE MONO 100 MG CAP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXYCYCLINE HYCLATE 100 MG CAP, is $0.1124 per EA — about 49% below DOXYCYCLINE MONO 100 MG CAP.

Who manufactures DOXYCYCLINE MONO 100 MG CAP?

DOXYCYCLINE MONO 100 MG CAP (NDC 62332025050) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.